Myriad Genetics Inc revenue
Myriad Genetics Inc's revenue was $825m in fiscal 2025, down 1.6% on the year before. Since fiscal 2009 ($327m) it has grown at a compound 6.0% a year. Over the last twelve months it was $807m.
Revenue history
| Fiscal year | 2009Jun 2009 | 2010Jun 2010 | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 327 | 363 | 402 | 496 | 613 | 778 | 723 | 754 | 771 | 744 | 851 | 639 | 691 | 678 | 753 | 838 | 825 | 807 |
| Growth on the year before | — | +11.1% | +10.9% | +23.4% | +23.6% | +26.9% | −7.1% | +4.2% | +2.3% | −3.6% | +14.4% | −25.0% | +8.1% | −1.8% | +11.0% | +11.2% | −1.6% | — |
| Gross profit | 283 | 318 | 356 | 445 | 549 | 682 | 590 | 621 | 626 | — | — | — | — | 476 | 517 | 585 | 577 | 555 |
| Gross margin | 86.7% | 87.8% | 88.6% | 89.6% | 89.5% | 87.7% | 81.6% | 82.4% | 81.2% | — | — | — | — | 70.2% | 68.6% | 69.9% | 69.9% | 68.8% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Hereditary Cancer | $372M | 45.2% | ▲ 2.2% |
| Prenatal | $186M | 22.6% | ▲ 5.2% |
| Mental Health | $144M | 17.5% | ▼ 15.3% |
| Tumor Profiling | $122M | 14.8% | ▼ 3.3% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $768M | 93.1% | ▼ 0.2% |
| Outside the US | $56.5M | 6.9% | ▼ 17.0% |
From Myriad Genetics Inc's 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Myriad Genetics Inc | $807m | -3.2% | 4.9% |
| Irhythm Holdings, Inc. | $825m | 25.6% | 22.2% |
| Orthofix Medical Inc. | $833m | 3.0% | 11.7% |
| Alphatec Holdings, Inc. | $840m | 15.3% | 23.1% |
| Varex Imaging Corp | $865m | 5.3% | -1.2% |
| Inspire Medical Systems, Inc. | $881m | -0.2% | 15.6% |
Compare with peers
- Irhythm Holdings, Inc. revenue
- Orthofix Medical Inc. revenue
- Alphatec Holdings, Inc. revenue
- Varex Imaging Corp revenue
- Inspire Medical Systems, Inc. revenue
Head to head: IRTC vs MYGNMYGN vs OFIXATEC vs MYGN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies